Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11779632 IL-2 muteins and uses thereof
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
March 15, 2021
Date of Patent
October 10, 2023
Patent Application Number
17201350
Patent Citations
US Patent 10294305 Method for treating a GD2 positive cancer
US Patent 10358477 IL-15Ralpha sushi domain—IL-15 fusion proteins
US Patent 10363273 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
US Patent 10363321 Nucleic acid products and methods of administration thereof
US Patent 10376564 Interleukin-2 for treating food allergy
US Patent 10428145 PD-1 binding proteins and methods of use thereof
US Patent 10493148 PD-1 agonist antibodies and uses thereof
US Patent 10676516 Targeted immunotolerance
US Patent 10751414 Methods of treating psoriasis using PD-1 binding antibodies
US Patent 10766958 Methods of treating vitiligo using PD-1 binding antibodies
•••
Patent Inventor Names
Jyothsna Visweswaraiah
Joanne L. Viney
Kevin Lewis Otipoby
Erik Robert Sampson
Nathan Higginson-Scott
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11779632
Patent Primary Examiner
Prema M Mertz
CPC Code
A61K 38/2013
Find more entities like US Patent 11779632 IL-2 muteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE